NO981386L - Stimulation of Cell-Mediated Immune Responses by Targeted Particular Genetic Immunization - Google Patents

Stimulation of Cell-Mediated Immune Responses by Targeted Particular Genetic Immunization

Info

Publication number: NO981386L
Authority: NO; Norway
Prior art keywords: stimulation; cell; immune responses; mediated immune; particular genetic
Prior art date: 1995-09-28

Application number

NO981386A

Other languages

Norwegian (no)

Other versions

NO981386D0 (en

Inventor

Louis D Falo Jr

Kenneth L Rock

Original Assignee

Univ Pittsburgh

Dana Farber Cancer Inst Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-09-28

Filing date

1998-03-26

Publication date

1998-05-28

1998-03-26 Application filed by Univ Pittsburgh, Dana Farber Cancer Inst Inc filed Critical Univ Pittsburgh

1998-03-26 Publication of NO981386D0 publication Critical patent/NO981386D0/en

1998-05-28 Publication of NO981386L publication Critical patent/NO981386L/en

Links

230000002068 genetic effect Effects 0.000 title 1
230000003053 immunization Effects 0.000 title 1
238000002649 immunization Methods 0.000 title 1
230000021633 leukocyte mediated immunity Effects 0.000 title 1
230000000638 stimulation Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/00119—Melanoma antigens
- A61K39/001192—Glycoprotein 100 [Gp100]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001102—Receptors, cell surface antigens or cell surface determinants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001102—Receptors, cell surface antigens or cell surface determinants
- A61K39/001103—Receptors for growth factors
- A61K39/001106—Her-2/neu/ErbB2, Her-3/ErbB3 or Her 4/ErbB4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001148—Regulators of development
- A61K39/00115—Apoptosis related proteins, e.g. survivin or livin
- A61K39/001151—Apoptosis related proteins, e.g. survivin or livin p53
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/00118—Cancer antigens from embryonic or fetal origin
- A61K39/001182—Carcinoembryonic antigen [CEA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001184—Cancer testis antigens, e.g. SSX, BAGE, GAGE or SAGE
- A61K39/001186—MAGE
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/00119—Melanoma antigens
- A61K39/001191—Melan-A/MART
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4615—Dendritic cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
- A61K39/4622—Antigen presenting cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterized by the route of administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the dose, timing or administration schedule

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Immunology (AREA)
Oncology (AREA)
Mycology (AREA)
Microbiology (AREA)
Cell Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
Virology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Engineering & Computer Science (AREA)
Gynecology & Obstetrics (AREA)
Reproductive Health (AREA)
Pregnancy & Childbirth (AREA)
Developmental Biology & Embryology (AREA)
Biotechnology (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Pulmonology (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

NO981386A 1995-09-28 1998-03-26 Stimulation of Cell-Mediated Immune Responses by Targeted Particular Genetic Immunization NO981386L (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US53555695A	1995-09-28	1995-09-28
PCT/US1996/015728 WO1997011605A1 (en)	1995-09-28	1996-09-27	Stimulation of cell-mediated immune responses by targeted particulate genetic immunization

Publications (2)

Publication Number	Publication Date
NO981386D0 NO981386D0 (en)	1998-03-26
NO981386L true NO981386L (en)	1998-05-28

Family

ID=24134735

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO981386A NO981386L (en)	1995-09-28	1998-03-26	Stimulation of Cell-Mediated Immune Responses by Targeted Particular Genetic Immunization

Country Status (15)

Country	Link
EP (1)	EP0863704A4 (en)
JP (1)	JPH11512724A (en)
KR (1)	KR19990063672A (en)
CN (1)	CN1201369A (en)
AU (1)	AU716497B2 (en)
BG (1)	BG102355A (en)
CA (1)	CA2233278A1 (en)
CZ (1)	CZ92998A3 (en)
HU (1)	HUP9802651A3 (en)
NO (1)	NO981386L (en)
NZ (1)	NZ319891A (en)
PL (1)	PL325953A1 (en)
SK (1)	SK40198A3 (en)
TR (1)	TR199800573T2 (en)
WO (1)	WO1997011605A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU3210997A (en) *	1996-05-24	1997-12-09	University Of Maryland At Baltimore	Dna vaccines for eliciting a mucosal immune response
TW570803B (en) *	1997-04-09	2004-01-11	Duphar Int Res	Influenza vaccine
US6287569B1 (en) *	1997-04-10	2001-09-11	The Regents Of The University Of California	Vaccines with enhanced intracellular processing
JP2002507392A (en) *	1998-02-11	2002-03-12	マキシジェン，インコーポレイテッド	Optimization of immunomodulatory properties of gene vaccines
AU2487300A (en)	1998-12-31	2000-07-31	Chiron Corporation	Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
WO2000063385A2 (en) *	1999-04-21	2000-10-26	Powderject Vaccines, Inc.	Nucleic acid immunization
CN1512894B (en) *	2001-03-30	2010-06-16	格林维尔医院***公司	Monocyte specific particulate delivery carrier
JP5033303B2 (en)	2001-07-05	2012-09-26	ノバルティスバクシンズアンドダイアグノスティックス，インコーポレーテッド	Polynucleotides encoding polypeptides with antigenic type C HIV, polypeptides and uses thereof
US11529414B2 (en)	2020-06-23	2022-12-20	Orbis Health Solutions, Llc	Viral vaccines for in vivo expression of a nucleic acid encoding an immunogenic peptide and methods of using the same

1996
- 1996-09-27 CN CN96198106A patent/CN1201369A/en active Pending
- 1996-09-27 AU AU72515/96A patent/AU716497B2/en not_active Ceased
- 1996-09-27 CZ CZ98929A patent/CZ92998A3/en unknown
- 1996-09-27 SK SK401-98A patent/SK40198A3/en unknown
- 1996-09-27 NZ NZ319891A patent/NZ319891A/en unknown
- 1996-09-27 CA CA002233278A patent/CA2233278A1/en not_active Abandoned
- 1996-09-27 EP EP96933987A patent/EP0863704A4/en not_active Withdrawn
- 1996-09-27 WO PCT/US1996/015728 patent/WO1997011605A1/en not_active Application Discontinuation
- 1996-09-27 KR KR1019980702134A patent/KR19990063672A/en not_active Application Discontinuation
- 1996-09-27 TR TR1998/00573T patent/TR199800573T2/en unknown
- 1996-09-27 PL PL96325953A patent/PL325953A1/en unknown
- 1996-09-27 HU HU9802651A patent/HUP9802651A3/en unknown
- 1996-09-27 JP JP9513762A patent/JPH11512724A/en active Pending
1998
- 1998-03-26 BG BG102355A patent/BG102355A/en unknown
- 1998-03-26 NO NO981386A patent/NO981386L/en unknown

Also Published As

Publication number	Publication date
PL325953A1 (en)	1998-08-17
HUP9802651A2 (en)	1999-02-01
WO1997011605A1 (en)	1997-04-03
BG102355A (en)	1999-04-30
EP0863704A1 (en)	1998-09-16
NO981386D0 (en)	1998-03-26
NZ319891A (en)	1999-01-28
CN1201369A (en)	1998-12-09
KR19990063672A (en)	1999-07-26
SK40198A3 (en)	1998-11-04
EP0863704A4 (en)	2003-09-10
CA2233278A1 (en)	1997-04-03
HUP9802651A3 (en)	2001-08-28
JPH11512724A (en)	1999-11-02
CZ92998A3 (en)	1998-09-16
AU7251596A (en)	1997-04-17
TR199800573T2 (en)	1998-07-21
AU716497B2 (en)	2000-02-24

Publication	Publication Date	Title
ZA9811501B (en)	2000-06-15	Method to enhance an immune response of nucleic acid vaccination.
NO975730D0 (en)	1997-12-05	Method of increasing protective immune responses
EP0814846A4 (en)	2001-08-22	Gene therapy by secretory gland expression
NO964713L (en)	1997-05-09	DNA-based vaccination of fish by immersion
NO961483D0 (en)	1996-04-12	Process for the treatment of oily formation
PL325522A1 (en)	1998-08-03	Method of obtaining spiorally coiled bristles
NO965107D0 (en)	1996-11-29	Copper-based catalysts, process for their preparation and use of the catalysts and process for the preparation of alkyl halogen silanes
NO981386L (en)	1998-05-28	Stimulation of Cell-Mediated Immune Responses by Targeted Particular Genetic Immunization
NO974089L (en)	1997-09-05	Stimulation of meiosis
NO986177L (en)	1999-02-15	Method of Preparation of Therapeutic DNA
ITBO940153A0 (en)	1994-04-12	METHOD FOR THE OPTICAL CONTROL OF PRODUCTS.
ITBO960142A0 (en)	1996-03-15	METHOD OF WRAPPING PRODUCTS
PT839001E (en)	2002-06-28	AROMATIZATION OF FOOD OILS
NO973193D0 (en)	1997-07-09	Collagen-based methods and formulations for the treatment of immune system-mediated diseases
IT1287176B1 (en)	1998-08-04	BURNER FOR HEATING APPLIANCES
KR960033768U (en)	1996-11-19	Hot wire fasteners of Schiropol cutter
KR970044493U (en)	1997-07-31	Safety net structure of fan heater
GB9503008D0 (en)	1995-04-05	Method of enhancing immune responses
IT235770Y1 (en)	2000-07-18	PRESENTER OF PRODUCTS FOR COMMERCIAL YEARS.
UA25747A (en)	1998-12-25	METHOD OF OBTAINING FORMED PRODUCTS
ITMO920059A1 (en)	1993-10-24	DISTRIBUTOR OF PRODUCTS, OBJECTS AND MANUFACTURED PRODUCTS, PARTICULARLY SUITABLE FOR DISTRIBUTOR APPLIANCES
IT1293256B1 (en)	1999-02-16	WINDING METHOD FOR GROUPS OF PRODUCTS.
SE9503073D0 (en)	1995-09-07	Method of heating buildings
KR960038133U (en)	1996-12-18	Thermostat of small boiler mat
UA25109A (en)	1998-12-25	METHOD OF CREATING CHOLODOX DUODOCHASTOMOSIS